A non-crosslinking platinum-acridine hybrid agent shows enhanced cytotoxicity compared to clinical BCNU and cisplatin in glioblastoma cells.

Source:http://linkedlifedata.com/resource/pubmed/id/15603970

Bioorg. Med. Chem. Lett. 2005 Jan 17 15 2 443-6

Download in:

View as

General Info

PMID
15603970